Company CVAbout Sudarshan Pharma Industries Ltd 
Sudarshan Pharma Industries Ltd
Micro Cap
Pharmaceuticals & Drugs
Sudarshan Pharma Industries Limited was originally incorporated as a Private Limited Company with the name "Sudarshan Specialty Chemsolve Private Limited" on July 23, 2008 with the Registrar of Companies, Mumbai. Later in the year 2016. name of the Company was changed from "Sudarshan Specialty Chemsolve Private Limited" to "Sudarshan Pharma Industries Private Limited" on 17 December 2016.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 24.07 Cr
Number of Shares
24.07 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
22-Nov-2024
24.07
24.07
216592983
1
Stock Split
17-Mar-2023
2.41
24.07
6862400
10
Public Issue
21-Nov-2022
1.72
17.20
5734489
10
Bonus Issue
07-Oct-2022
1.15
11.47
350000
10
Loan Conversion
30-Sep-2022
1.11
11.12
1370000
10
Private Placement
26-Dec-2021
97.49
9.75
202000
10
Private Placement
09-Jan-2019
95.47
9.55
945285
10
Private Placement
06-Dec-2018
86.02
8.60
578257
10
Private Placement
27-Aug-2018
80.23
8.02
3303774
10
Bonus Issue
08-Mar-2018
47.2
4.72
1155556
10
Right Issues
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 5 FIIs (13.07%)
Promoter with highest holding
Sachin Vasantrai Mehta (27.51%)
Highest Public shareholder
Ag Dynamic Funds Limited (3.99%)
Individual Investors Holdings
23.2%
Board of Directors
Management
Designation
Remuneration
Hemal V Mehta
Managing Director
0
Sachin V Mehta
Joint Managing Director & CFO
0
UJWALA VILAS SALVI
Director
0
SUBHASH GOVERDHANDASJI BISSA
Director
0
Rushabh Prashant Patil
Additional Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Formulation & Chemical-Purchas
132.8514
0%
Formulation & Chemical-Purchas
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
Pharmaceuticals & Drugs
INR 725 Cr (Micro Cap)
64.00
33
0.00%
0.94
10.18%
6.50
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
